High-yielding syntheses of hydrophilic conjugatable chlorins and bacteriochlorins.
Next-generation photodynamic therapy agents based upon the conjugation of multiple photosensitizers to a targeting backbone will allow for more efficacious light-based therapies. To this end, we have developed glucose-modified chlorins and bacteriochlorins featuring a reactive carboxylic acid linker for conjugation to targeting moieties. The photosensitizers were synthesized in relatively high yields from meso-tetra(p-aminophenyl)porphyrin, and resulted in neutral, hydrophilic chromophores with superb absorption profiles in the far-red and near-infrared portions of the electromagnetic spectrum. In addition, conjugation of these photosensitizers to a model nanoscaffold (crosslinked dextran-coated nanoparticles) demonstrated that the inclusion of hydrophilic sugar moieties increased the number of dyes that can be loaded while maintaining suspension stability. The described compounds are expected to be particularly useful in the synthesis of a number of targeted nanotherapeutic systems.
McCarthy
Jason R
JR
Center for Molecular Imaging Research, Harvard Medical School and Massachusetts General Hospital, 149 13th St., Rm 5406, Charlestown, MA 02129, USA. jason_mccarthy@hms.harvard.edu
Bhaumik
Jayeeta
J
Merbouh
Nabyl
N
Weissleder
Ralph
R
D003432:Cross-Linking Reagents; D005947:Glucose / Q000737:chemistry; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000138:chemical synthesis*; D011166:Porphyrins / Q000737:chemistry*; D055672:Static Electricity; D013329:Structure-Activity Relationship
D003432:Cross-Linking Reagents; D017319:Photosensitizing Agents; D011166:Porphyrins; C452433:bacteriochlorin; C006969:chlorin; D005947:Glucose
ChemMedChem. 2006 Apr;1(4):458-63
16892381
J Biophotonics. 2008 Oct;1(5):395-407
19343663
Bioconjug Chem. 1999 Nov-Dec;10(6):982-92
10563767
Bioconjug Chem. 2001 Sep-Oct;12(5):691-700
11562187
J Org Chem. 2008 Aug 1;73(15):5806-20
18576691
Nucleic Acids Res. 2009 Feb;37(3):866-76
19103663
Small. 2006 Aug;2(8-9):983-7
17193154
J Am Chem Soc. 2004 Sep 15;126(36):11128-9
15355075
Eur J Pharm Biopharm. 2003 Jan;55(1):115-24
12551712
J Org Chem. 2005 May 13;70(10):4107-17
15876103
Eur J Pharm Biopharm. 2008 Aug;69(3):1083-93
18396019
Bioconjug Chem. 2007 Mar-Apr;18(2):494-9
17279724
Br J Pharmacol. 2008 May;154(1):1-3
18362894
Nat Med. 2003 Jan;9(1):123-8
12514725
J Am Chem Soc. 2003 Jul 2;125(26):7860-5
12823004
Eur J Pharm Sci. 2003 Mar;18(3-4):241-9
12659935
Org Lett. 2002 Oct 17;4(21):3675-8
12375916
Cancer Res. 2000 Aug 1;60(15):4200-5
10945630
Org Biomol Chem. 2009 Mar 7;7(5):874-88
19225670
Br J Cancer. 2005 Apr 25;92(8):1442-9
15812551
Lasers Surg Med. 2001;29(4):314-22
11746108
Nano Lett. 2005 Dec;5(12):2552-6
16351214
Lancet Oncol. 2004 Aug;5(8):497-508
15288239
Cancer Lett. 2009 Sep 8;282(1):63-76
19346065
ChemMedChem. 2007 Mar;2(3):360-5
17245681
Photochem Photobiol. 2003 Jun;77(6):638-44
12870850
Anticancer Agents Med Chem. 2008 Apr;8(3):241-68
18393785